• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Bristol Myers Squibb Expands at Cambridge Crossing

    Amgen Completes Five Prime Acquisition

    Sartorius Expands in the UK

    Obituary Notice: Russell “Russ” Haines

    Abenza Chooses North Carolina for New Biologics Manufacturing Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Bristol Myers Squibb Expands at Cambridge Crossing

    Amgen Completes Five Prime Acquisition

    Sartorius Expands in the UK

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Arkema Recruits Dotmatics as its R&D Digitalization Partner
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    PCI Pharma Services

    Alcami

    Quotient Sciences

    Aphena Pharma Solutions

    Reed-Lane
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions

    PCI Pharma Services

    Quotient Sciences

    Reed-Lane

    Adare Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Trends in Solid Oral Dosage Delivery

    Capsule demand continues to rise due to this delivery system’s versatility.

    Trends in Solid Oral Dosage Delivery
    Trends in Solid Oral Dosage Delivery
    Figure 1: Combination fill.
    Trends in Solid Oral Dosage Delivery
    Figure 2: Liquid-solid combination capsules
    Anita Solanki, Milind Biyani and Jnanadeva Bhat, PhD , ACG Capsules03.01.21
    Pharmaceutical dosage form encompasses various administration routes like oral, injectables, topical, rectal, and pulmonary. The demand for solid orals as a dosage form is unparalleled. When we consider any pharmaceutical dosage form, the preferred choice is oral dosage form such as tablets and capsules. It is self-administered and non-invasive, unlike injectables, where dependencies are unavoidable. In fact, the demand for empty hard capsules is currently at approximately 700 billion units, and it seems like a trend that will continue to rise. Much of this demand is owed to this delivery system's versatility. 

    In the cluttered pharma market, to gain a competitive advantage or enhance existing formulations, there is an increased focus on developing 505(b)(2) improvements. These upgrades include enhancing bioavailability, changing dosage forms, new therapeutic indications, changing the route of administration, substitutions in combination products, new dosing regimens, and so on. Solid oral dosages provide an ideally suited and cost-effective platform for all such efforts due to the large variety of available options, sizes, and sophisticated manufacturing processes. There is also a push to transform newer therapeutic forms like peptides and biologics into easily consumable oral forms. The nutraceutical market is no different from pharmaceuticals and follows similar trends. The nutraceutical dosage form primarily includes only oral dosage forms.

    This vast demand for solid oral dosages has also led to a broad array of customization, as well as the introduction of innovative technologies and materials to suit the specific needs of consumer segments, new actives, and varied formulations. Let us look at some of these trends and recent advancements in this space.

    Trends in Pharmaceuticals
    Patient-centric care
    Patient-centricity continues to be the most significant trend in medicine and reflects all aspects of therapy, including solid oral drug formulations. Making solid orals easy to swallow and masking unpleasant taste and odor are core tenets of making drugs more patient-friendly. Formulation of sprinkle capsules, mini or micro-tablets also can make medicines easier to swallow, especially for pediatric and geriatric populations. Fast-dissolving, fast-dispersing, or fast-melting formulations are more acceptable to these special populations. Other ways of devising patient-friendly dosages that can increase compliance include segmented easy-to-score tablets, gel-forming easy-to-swallow oral films, multiple scored tablets, and solid dosage pen devices.

    Inhaled drugs: the new frontier
    Among the fastest expanding markets are inhalers. Various drugs are being formulated for use in inhalers, including interferons used in anti-cancer and anti-viral therapies; one such inhaled drug is being tested for Covid-19. Capsules are convenient to use in dry powder inhalers, meaning they may even play a role in improving patient adherence to therapy over reservoir or blister-based systems that can be complicated to use. Gelatin or HPMC (Hydroxy Propyl Methyl Cellulose) capsules can be suitable for hygroscopic molecules popularly used in inhalers. Such re-formulations are another trend amid the increased focus on patient-centric care.

    Compartmentalizing combined APIs
    Combination products are another trend, with many gaining approval in the U.S. and the world over. Combination products are designed with multiple active ingredients and technologies to avoid several challenges associated with formulations. Combination fill offers a wide array of development options like immediate release with sustained release or delayed-release. Capsule inside a capsule provides a unique advantage to avoid drug-drug interaction and incompatibilities. Multiple pellets filling in capsules offer a great degree of uniformity by preventing the segregation of pellets. Mini- and micro-tablets can provide accuracy in weight variation and dose apart from different release options. The use of various therapies and doses can be incorporated together into a single capsule for combination therapy. Hard capsules enable filling powders, pellets, mini or micro tablets, or even another capsule in the same pill for offering fixed-dose combinations, once-daily combination, multi-drug resistance therapies, and avoiding missing doses (see Figure 1).


    Figure 1. Combination fill.

    Complex oral delivery systems for novel therapeutics
    For the delivery of insoluble drugs, biologics, peptides, and other novel forms of therapeutics, complex dosage forms are evolving.

    Poor water solubility is a considerable challenge in approximately 90% of drugs in the development and approval pipeline. Methods being employed to improve solubility are micronization or nano-milling, which reduces the size of API particles. Creating solid dispersions in a carrier polymer like HPMC is another technique that can increase solubility by avoiding the creation of insoluble API crystals. Lipid or polymer-based systems are also employed to encapsulate these insoluble drugs. Polymeric (PLGA) particles, solid-lipid particles, liposomes, and reverse cubic phase particles are popular technologies toward this goal.

    Biologics and peptides are commonly found as injectables, but there is a need to evolve them into oral and nasal forms to enhance patient compliance. Absorption enhancers, conjugation with other entities, and gastro-retentive delivery systems are increasingly being used to achieve these drugs' oral administration.

    Robotic pills
    A robotic pill is a capsule that dissolves in the gut's acidic environment, which in turn prompts a valve with a chemical compartment of acids to release carbon dioxide. The carbon dioxide gas inflates a balloon-like structure that releases microneedles of sugar-coated with the peptide drug into the body.

    Harnessing 3D printing for customized dosing
    3D printing is revolutionizing every manufacturing industry. For pharmaceuticals, 3D printing brings the versatility needed to develop novel dosage forms rapidly and at a low cost. Through this technology, it is now possible to create complex drugs and house multiple actives in one single dosage form. These can also be designed to have customized release profiles and even individualized designs adapted per patient needs. One fascinating aspect is production flexibility, as the 3D printing of these drugs can often occur at a pharmacist's lab or even a patient's own home. 3D printing will soon clear the proof-of-concept stage and emerge into a widely accepted manufacturing tool with a bevy of potential benefits. However, this has already become a reality in the dietary supplement segment.

    Tackling counterfeiting with micro tags and DNA tagging
    WHO reports that at least 1 in 10 medical products in developing countries is falsified or sub-standard. Complex supply chains and online sales often make it difficult to track products and their distribution, creating opportunities for counterfeiters. Counterfeiting is not only a significant hazard for health and safety but can also cause loss of trust and revenue for brand owners, and estimated monetary losses approach up to $200 billion annually. The conventional methods of using packaging codes to counterfeit may no longer be enough.

    A novel way of fighting these fake medicines is creating micro tags made of inert materials like silicon dioxide, invisible printing, and DNA printing with multiple security codes printed on their surface. The size of an average micro tag is 50–110 µm—the size of a dust speck. These tags can be printed either inside or outside the capsule surface without changing existing manufacturing processes. Similarly, for tablets, these taggants can be included in coating or printing.   

    Trends in Nutraceuticals Immunity boosters
    The Covid-19 pandemic has demanded near-total attention in the past year and continues to do so. Due to the lack of a cure, boosting the body's immunity has become the reliant method for fighting this disease. Most immune-boosting formulations are plant-based, Ayurvedic products, micronutrient supplements, or probiotics that are easily formulated and delivered in solid oral formats. Not only in Covid-19, but immunity boosters are also essential for the body in general to prevent the occurrence of any diseases.

    Moving toward vegetarian sources
    Replacing animal-origin gelatin with materials of vegetarian sources such as cellulose, starch, carrageenan, and pullulan (polysaccharide) has gained momentum, with the trend toward vegan and vegetarian lifestyles. There is an increase in demand for HPMC (Hydroxy Propyl Methyl Cellulose) capsules mainly driven by nutraceuticals, herbals, and dietary supplements such as vitamins and minerals.

    Time-dependent DR (Delayed-Release) HPMC capsules help protect probiotics, enzymes, and other acid-sensitive ingredients from degrading in the stomach. These capsules' delayed-release mechanism helps deliver ingredients that can irritate the gastric mucosa and acid reflux—for example, garlic oil, fish oil, mint, or krill oil. They can also mask unpleasant odors and diminish bad aftertaste for a more patient-friendly experience.

    For formulations where moisture significantly affects the product's activity, HPMC capsules offer a suitable alternative to gelatin-based capsules, owing to HPMC capsule comparably low inherent moisture content of 3-8%.

    Demand for HPMC capsules without gelling agents is also increasing. HPMC capsules are also useful for actives incompatible with gelatin capsules, are resistant to cross-linking, and offer superior stability for hygroscopic products.

    Liquid-solid combinations
    Commonly, liquid filling in hard capsules is more advantageous than with soft gelatin capsules and allows effortless, more efficient manufacturing of small-scale batches during development trials.

    Combination filling is a distinctive concept where hard capsules encapsulate incompatible ingredients to offer multidose and multiphasic delivery in single capsules. Combinations like capsule inside a capsule, tablet in liquid-filled capsule, and pellets in liquid-filled capsule are possible in liquid encapsulation (see Figure 2).


    Figure 2. Liquid-solid combination capsules.

    Capsule in a capsule: Two incompatible active ingredients can be incorporated into one capsule to avoid stability or incompatibility concerns. One compound can be dissolved or dispersed in a liquid, while the other can be encapsulated in a smaller capsule to segregate two actives effectively.

    Tablet in a capsule: Different nutraceutical active ingredients can be incorporated into one dosage form to obtain customized release profiles. The ingredient in solution form can deliver an immediate release, while the tablet can give delayed-release.

    Pellets in a capsule: Pellets can be incorporated into a capsule to obtain sustained release profiles, with one active ingredient dissolved in a liquid for immediate absorption.

    Eco, Green, Clean
    These labels symbolize the brand's commitment to environmental issues. The rise of the green consumer who actively avoids non-sustainable goods has made many brands find ways to reduce their ecological footprint. Many fast-moving consumer goods (FMCG) and cosmetics companies have stated their commitment to achieving 100% sustainable manufacturing and packaging products. Ecofriendly labels have become a valuable opportunity to increase brand equity for the consumer.      

    ACG has received a certification of compliance from the U.S.-based Clean Label Project for its H+ capsules—the first capsules to receive such a designation. The Clean Label distinction requires materials to be free of over 400 industrial and environmental contaminants, in addition to meeting consumable safety requirements laid out by the U.S. FDA. 


    References
    • Radhakrishnan A, Kuppusamy G, Ponnusankar S, Shanmukhan NK. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery. The pharmacogenomics journal. 2020;20(1):1-8.
    • J.Sanjiv Mervyn et al. Int.J. PharmTech Res.2014-2015;7(3):432-437
    • Samiei N. Recent trends on applications of 3D printing technology on the design and manufacture of pharmaceutical oral formulation: a mini review. Beni-Suef University Journal of Basic and Applied Sciences. 2020;9:1-2.
    • Liang, W et al. Pulmonary Delivery of Biological Drugs. Pharmaceutics 2020:12(1025); doi:10.3390/pharmaceutics12111025
    • Hassani, L, Lewis, A, Richard J. Oral Peptide Delivery: Technology Landscape & Current Status. Fredrick Furness Publishing 2015.
    • https://pharma-trends.com/2020/03/30/the-reign-of-oral-solid-dosage-forms-in-the-era-of-biopharmaceuticals/
    • https://www.statnews.com/2019/05/07/stopping-murder-counterfeit-medicine/
    • https://www.pharmtech.com/view/authenticating-drugs-edible-microtags
    • https://cen.acs.org/articles/93/i8/Fighting-Fake-Drugs.html
    Related Searches
    • Drug Delivery

    Related Features

    • Drug Delivery | Parenterals
      Injectable Drug Delivery Trends

      Injectable Drug Delivery Trends

      How medication trends are driving the shift to patient-friendly drug delivery systems.
      Peter Soelkner, Managing Director, Vetter 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Oral Solids:   Market & Technology Trends

      Oral Solids: Market & Technology Trends

      Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.
      Tim Wright, Editor, Contract Pharma 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Medicated Chewing Gum: A Modern Oral Drug Delivery System

      Medicated Chewing Gum: A Modern Oral Drug Delivery System

      Development and manufacture of medicated chewing gum continues to gain momentum.
      Rukayat Adedeji, Contributing Writer 03.01.21


    • Drug Delivery
      Inhaled Drug Delivery Technology

      Inhaled Drug Delivery Technology

      The success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology being chosen for its delivery.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 01.27.21

    • Drug Delivery | Injectables
      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Bringing together self-medication with auto-injectors and sustainable secondary packaging.
      Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20

    • Drug Delivery
      Wet Wipes Increased Prevalence in Drug Development

      Wet Wipes Increased Prevalence in Drug Development

      A number of factors including patient preference are driving the growth of wet wipes in pharma.
      John Waddell, Business Development Director – Pharma, PDI Contract Manufacturing 10.14.20


    • Drug Delivery
      Not Your Father’s Oral Thin Film

      Not Your Father’s Oral Thin Film

      A look at how oral film drug delivery is evolving.
      Rodolphe Obeid, Vice President of Operations, IntelGenx 06.04.20

    • Drug Delivery | Regulatory Affairs
      Regulatory Overhaul for Medical Devices

      Regulatory Overhaul for Medical Devices

      Implications for the pharmaceutical industry.
      Elizma Parry, Director, Global Clinical Practice, Maetrics 06.04.20

    • Drug Delivery
      CEO Spotlight: Will Downie

      CEO Spotlight: Will Downie

      Vectura’s chief executive talks trends in the inhaled-drug market, and the company’s transition into a CDMO
      Tim Wright, Editor, Contract Pharma 04.01.20


    • Biologics, Proteins, Vaccines | Drug Delivery | Drug Development
      Knowledge Sharing: Biologics Development and Delivery

      Knowledge Sharing: Biologics Development and Delivery

      The increasing importance of sharing information to build awareness and better manage the complexities of drug development.
      Fran L. DeGrazio, Vice President of Scientific Affairs and Technical Services, West Pharmaceutical Services 09.16.19

    • Drug Delivery
      Nasal Drug Delivery

      Nasal Drug Delivery

      A look at best practices for testing nasal drug delivery devices
      Maria Smith, senior manager & Charles Shaw, scientific advisor, Renaissance Lakewood LLC 01.25.19

    • Drug Delivery | Drug Development
      Traveling Toward the Intersection of Drug Development and Delivery

      Traveling Toward the Intersection of Drug Development and Delivery

      Overcoming the challenges of delivering drugs to patients.
      Louise Righton, Global Marketing Operations Manager, 3M Drug Delivery Systems 06.12.18


    • Drug Delivery | Solid Dosage/Creams/Ointments
      FDCs on the Rise

      FDCs on the Rise

      Fixed-dose combination drugs continue to gain traction due to a multitude of benefits they offer, including speed to market a
      Betsy Louda, Associate Editor, Contract Pharma 03.09.18

    • Drug Delivery
      The Future of Inhaled Medications and Inhalation Technology

      The Future of Inhaled Medications and Inhalation Technology

      Formulations, devices and strategy through non-clinical development
      Simon Moore, Envigo 10.11.17

    • Drug Delivery
      Digital Drug Delivery: A Snapshot in Time

      Digital Drug Delivery: A Snapshot in Time

      Technology is transforming the future of drug delivery
      Sam Van Alstyne, 3M Drug Delivery Systems 10.11.17

    Trending
    • Thermo Fisher Acquires PPD For $17.4B
    • Abenza Chooses North Carolina For New Biologics Manufacturing Site
    • Executive Moves: Novavax
    • Bristol Myers Squibb Expands At Cambridge Crossing
    • Ensuring Pharma Manufacturing Quality
    Breaking News
    • Bristol Myers Squibb Expands at Cambridge Crossing
    • Amgen Completes Five Prime Acquisition
    • Sartorius Expands in the UK
    • Obituary Notice: Russell “Russ” Haines
    • Abenza Chooses North Carolina for New Biologics Manufacturing Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    IGL Coatings Announces Partnership in Finland
    Axalta Schedules 1Q 2021 Earnings Conference Call
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb Expands at Cambridge Crossing
    Amgen Completes Five Prime Acquisition
    Sartorius Expands in the UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Former L’Oréal Exec Joins Glossier
    Lancôme Reveals New Global Sustainability Program
    First-Ever Skincare Line Focuses on Iron To Prevent Aging
    Happi

    Latest Breaking News From Happi

    Fragrance Creators Association Celebrates P&G Executive
    Evonik Highlights Solutions for Malodor Reduction
    P&G Emphasizes Small Actions at Home To Be More Sustainable
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Albaad to Add Natural-Based Line in Israel
    First Quality to Discontinue Tampon Operations
    Jessup Installs New Era Coating and Laminating Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Biogennix Rolls Out Agilon Strip Bone Graft
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login